Recipharm bolsters its inhalation and injectables manufacturing with $650M deal for Consort Medical

18th November 2019 Uncategorised 0

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures

More: Recipharm bolsters its inhalation and injectables manufacturing with 0M deal for Consort Medical
Source: fierce